VALIDATION OF THE SUITABILITY OF A NOVEL ELISPOT ASSAY TO ASSESS THE FUNCTIONALITY OF CELL-MEDIATED IMMUNITY (CMI) IN HEMODIALYSIS PATIENTS

Banas, B. and Boeger, C. and Lueckhoff, G. and Krueger, B. and Boeckl, K. and Batzilla, J. and Bendfeldt, H. and Schemmerer, M. and Koestler, J. and Barabas, S. and Wagner, R. and Deml, L. and Leicht, J. and Kraemer, B. K. (2015) VALIDATION OF THE SUITABILITY OF A NOVEL ELISPOT ASSAY TO ASSESS THE FUNCTIONALITY OF CELL-MEDIATED IMMUNITY (CMI) IN HEMODIALYSIS PATIENTS. TRANSPLANT INTERNATIONAL, 28 (Suppl3). p. 17. ISSN 0934-0874, 1432-2277

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin II
Medicine > Lehrstuhl für Medizinische Mikrobiologie und Hygiene
Depositing User: Petra Gürster
Date Deposited: 26 Aug 2020 05:50
Last Modified: 26 Aug 2020 05:50
URI: https://pred.uni-regensburg.de/id/eprint/4725

Actions (login required)

View Item View Item